and its subsidiary’s net profits resulted from the growth of revenue, the decrease in the proportion of the cost of hospital operations to the total revenue and the decrease in financing cost. Statement
% decrease. The promising growth of non-SW revenue was from IPD (49% growth) followed by OPD (14% growth) yoy. Both number of patients and revenue per head of 4Q19 increased. The higher revenue per head
17.74% 20.03 9.21% 49.42 246.73% Jul – Sep 63 Jul – Sep 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2
Execution due to Acquisition or Disposal of Assets”. 3.3 The reason of the acquisition Due to the overall of automotive group business has rapid change and continuing decrease the growth and slow down
information Disclosure and Execution due to Acquisition or Disposal of Assets”. 3.3 The reason of the acquisition Due to the overall of automotive group business has rapid change and continuing decrease the
and Execution due to Acquisition or Disposal of Assets”. 3.3 The reason of the acquisition Due to the overall of automotive group business has rapid change and continuing decrease the growth and slow
measurement in several countries resulting a significant decrease across economic activities which expected a deep economic deceleration throughout the year. During the last period shrinking economy impacted
measurement in several countries resulting a significant decrease across economic activities which expected a deep economic deceleration throughout the year. During the last period shrinking economy impacted
beverages 100.94 102.93 (1.99) (1.9) Other revenue from operations 72.51 70.82 1.69 2.4 Total revenues 453.57 446.69 6.88 1.5 (million) 2018 2017 increase (decrease) 2 Other income Other income for the second
(9.36) (15.8) Total revenues 458.81 516.51 (57.70) (11.2) (million) 2019 2018 increase (decrease) 2 Other income Other income for the first quarter of the year 2019 of Baht 5.54 million increased from the